GlaxoSmithKline heart disease treatment fails when compared to placebo in late-stage study

  • by: TOM MURPHY , Associated Press
  • Updated: November 12, 2013 - 9:25 AM

A potential GlaxoSmithKline heart disease treatment acquired in a key company takeover fell short in a big, late-stage study.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT